×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Third Harmonic Bio Inc. (THRD) NASDAQ

$13.33 (0.51) (-3.69%)

Market Cap: $545.86M

As of 06/14/24 04:00 PM EDT. Market closed.

(THRD)

Third Harmonic Bio Inc. (THRD)
NASDAQ

$13.33
(0.51) (-3.69%)

Market Cap: $545.86M

As of 06/14/24 04:00 PM EDT. Market closed.

Add to Portfolio

third harmonic bio is a clinical-stage company developing a highly selective, oral kit inhibitor for treatment of severe allergy and inflammation. kit is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
26
URL
Address
.
PRICE CHART FOR THIRD HARMONIC BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.05
Previous Close
$13.84
Days Range
$13.31 - $13.87
52 week range
$4.72 - $16.94
Volume
49,633
Avg. Volume (30 days)
92,313
Market Cap
$545.86M
Dividend Yield
-
P/E
-
Shares Outstanding
40,949,463
Open
$14.05
Previous Close
$13.84
Days Range
$13.31 - $13.87
52 week range
$4.72 - $16.94
Volume
49,633
Avg. Volume (30 days)
92,313
Market Cap
$545.86M
Dividend Yield
-
P/E
-
Shares Outstanding
40,949,463
FINANCIAL STATEMENTS FOR THIRD HARMONIC BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR THIRD HARMONIC BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Dittman JenniferChief Development Oper OfficerJun 07, 2024 Option Exercise$4.204942,075494Jun 10, 2024, 04:26 PM
Dittman JenniferChief Development Oper OfficerJun 07, 2024 Sale$14.174947,0000Jun 10, 2024, 04:26 PM
Dittman JenniferChief Development Oper OfficerMay 20, 2024 Option Exercise$4.301,0424,4811,042May 22, 2024, 04:36 PM
Dittman JenniferChief Development Oper OfficerMay 20, 2024 Sale$14.001,04214,5880May 22, 2024, 04:36 PM
Dittman JenniferChief Development Oper OfficerMay 16, 2024 Option Exercise$4.2723,578100,69423,578May 20, 2024, 04:33 PM
Dittman JenniferChief Development Oper OfficerMay 16, 2024 Sale$14.0423,578331,0660May 20, 2024, 04:33 PM
Holles Natalie C.CEOMay 09, 2024 Option Exercise$4.2020,22284,9321,239,058May 10, 2024, 04:04 PM
Holles Natalie C.CEOMay 09, 2024 Sale$12.1820,222246,3001,218,836May 10, 2024, 04:04 PM
Holles Natalie C.CEOApr 11, 2024 Option Exercise$4.2013,55856,9441,232,394Apr 15, 2024, 04:14 PM
Holles Natalie C.CEOApr 11, 2024 Sale$12.1913,558165,2141,218,836Apr 15, 2024, 04:14 PM
Person JulieCHIEF ADMINISTRATIVE OFFICERApr 04, 2024 Option Exercise$4.201,1074,6491,107Apr 08, 2024, 05:21 PM
Person JulieCHIEF ADMINISTRATIVE OFFICERApr 04, 2024 Sale$10.001,10711,0700Apr 08, 2024, 05:21 PM
Person JulieChief Administrative OfficerDec 05, 2023 Option Exercise$4.2012,86354,02512,863Dec 07, 2023, 04:04 PM
Person JulieChief Administrative OfficerDec 05, 2023 Sale$10.3012,863132,4840Dec 07, 2023, 04:04 PM
Conner Edward R.Chief Medical OfficerDec 05, 2023 Option Exercise$4.204,79020,1184,790Dec 07, 2023, 04:03 PM
Conner Edward R.Chief Medical OfficerDec 05, 2023 Sale$10.034,79048,0620Dec 07, 2023, 04:03 PM
BVF PARTNERS L P/IL10% OwnerDec 20, 2022 Buy$4.11214,063879,4992,332,638Dec 22, 2022, 06:49 PM
ORBIMED ADVISORS LLCDirectorSep 19, 2022 Buy$17.00300,0005,100,0005,779,071Sep 21, 2022, 06:00 PM
Bonita David PDirectorSep 19, 2022 Buy$17.00300,0005,100,0005,779,071Sep 21, 2022, 05:59 PM
Atlas Venture Fund XI, L.P.10% OwnerSep 19, 2022 Buy$17.00300,0005,100,00010,313,763Sep 19, 2022, 04:51 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Dittman JenniferChief Development Oper Officer06/07/20242,075
Dittman JenniferChief Development Oper Officer06/07/20247,000
Dittman JenniferChief Development Oper Officer05/20/20244,481
Dittman JenniferChief Development Oper Officer05/20/202414,588
Dittman JenniferChief Development Oper Officer05/16/2024100,694
Dittman JenniferChief Development Oper Officer05/16/2024331,066
Holles Natalie C.CEO05/09/202484,932
Holles Natalie C.CEO05/09/2024246,300
Holles Natalie C.CEO04/11/202456,944
Holles Natalie C.CEO04/11/2024165,214
Person JulieCHIEF ADMINISTRATIVE OFFICER04/04/20244,649
Person JulieCHIEF ADMINISTRATIVE OFFICER04/04/202411,070
Person JulieChief Administrative Officer12/05/202354,025
Person JulieChief Administrative Officer12/05/2023132,484
Conner Edward R.Chief Medical Officer12/05/202320,118
Conner Edward R.Chief Medical Officer12/05/202348,062
BVF PARTNERS L P/IL10% Owner12/20/2022879,499
ORBIMED ADVISORS LLCDirector09/19/20225,100,000
Bonita David PDirector09/19/20225,100,000
Atlas Venture Fund XI, L.P.10% Owner09/19/20225,100,000
Load More Insider Transactions
FUNDS WITH A POSITION IN THIRD HARMONIC BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC5,779,0711%No changeOther
RA CAPITAL MANAGEMENT, L.P.2,033,0560.25%No changeOther
BLACKROCK INC.1,362,2920.0003%-1.94%Other
GEODE CAPITAL MANAGEMENT, LLC400,0680.00035%-0.16%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.152,0270.00345%ExitedOther
RENAISSANCE TECHNOLOGIES LLC68,3000.00101%425.38%Other
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)48,4030.03%-25.19%Value
D. E. SHAW & CO., INC.28,9740.00023%8.27%Other
CHANGE IN SHARES OUTSTANDING FOR THIRD HARMONIC BIO INC
STOCK BUYBACKS FOR THIRD HARMONIC BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.84%
1Q
03/31/2024
09/30/2023
1.32%
2Q
03/31/2024
06/30/2023
1.62%
3Q

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.84%
1Q
09/30/2023
1.32%
2Q
06/30/2023
1.62%
3Q
BUYBACK ANNOUNCEMENT(S) FOR THIRD HARMONIC BIO INC
LOADING...